Scarica l'app Stockscreener
122.76
0.00%
0.00
Dopo l'orario di chiusura:
122.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$122.76
Aprire:
$123.18
Volume 24 ore:
366.32K
Relative Volume:
0.57
Capitalizzazione di mercato:
$5.43B
Reddito:
$3.04B
Utile/perdita netta:
$191.94M
Rapporto P/E:
28.90
EPS:
4.2479
Flusso di cassa netto:
$396.44M
1 W Prestazione:
-1.39%
1M Prestazione:
+7.29%
6M Prestazione:
+2.75%
1 anno Prestazione:
-31.61%
Intervallo 1D:
$122.04
$123.55
Intervallo di 1 settimana:
$120.77
$124.77
Portata 52W:
$102.58
$185.94
Teleflex Incorporated Stock (TFX) Company Profile
Nome
Teleflex Incorporated
Settore
Industria
Telefono
610-225-6800
Indirizzo
550 E SWEDESFORD RD, WAYNE, PA
Confronta TFX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TFX
Teleflex Incorporated
|
122.76 | 5.43B | 3.04B | 191.94M | 396.44M | 4.2479 |
|
ISRG
Intuitive Surgical Inc
|
575.40 | 204.83B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.16 | 55.94B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.35 | 39.48B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
242.85 | 35.73B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.00 | 34.74B | 27.43B | 1.27B | 1.01B | 1.5829 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-04 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-02-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-02-28 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2025-02-27 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-07-01 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-12-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-06-21 | Downgrade | Needham | Buy → Hold |
| 2023-05-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-04-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2022-10-26 | Iniziato | Mizuho | Neutral |
| 2022-10-14 | Ripresa | Stephens | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-29 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-09 | Iniziato | BofA Securities | Neutral |
| 2022-04-13 | Iniziato | Truist | Hold |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-07 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-09-07 | Ripresa | Raymond James | Outperform |
| 2021-07-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-01-06 | Reiterato | Needham | Buy |
| 2020-11-02 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2019-08-02 | Reiterato | Needham | Buy |
| 2019-06-11 | Iniziato | Wells Fargo | Outperform |
| 2019-04-24 | Downgrade | Needham | Strong Buy → Buy |
| 2019-02-22 | Reiterato | Needham | Strong Buy |
| 2018-10-16 | Iniziato | Barclays | Equal Weight |
| 2018-09-10 | Aggiornamento | Needham | Buy → Strong Buy |
| 2018-08-03 | Reiterato | Needham | Buy |
| 2018-05-14 | Reiterato | Needham | Buy |
| 2018-05-04 | Reiterato | Needham | Buy |
| 2018-04-04 | Iniziato | Goldman | Neutral |
| 2017-11-10 | Ripresa | Piper Jaffray | Overweight |
| 2017-11-03 | Reiterato | Needham | Buy |
| 2017-09-08 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2017-09-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-09-06 | Reiterato | Needham | Buy |
| 2017-03-07 | Iniziato | Needham | Buy |
| 2017-01-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2016-07-12 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
Mostra tutto
Teleflex Incorporated Borsa (TFX) Ultime notizie
We Think Teleflex (NYSE:TFX) Can Stay On Top Of Its Debt - 富途牛牛
Teleflex Incorporated (TFX) Stock Price History & Data - Traders Union
Teleflex to Present at the Deutsche Bank 38th Annual Health Care Conference - AOL.com
Teleflex Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Teleflex Inc. stock outperforms competitors on strong trading day - MarketWatch
Is Teleflex Attractively Priced After Sharp Five Year Slide and DCF Concerns in 2025 - Yahoo Finance
Teleflex Incorporated (TFX): A bull case theory - MSN
Teleflex Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Teleflex (TFX): Reassessing Valuation After Recent Share Price Pullback and Mixed Long-Term Returns - Yahoo Finance
Published on: 2025-12-22 07:50:00 - moha.gov.vn
Wedge Capital Management L L P NC Takes Position in Teleflex Incorporated $TFX - MarketBeat
Will Teleflex Incorporated (TBH) stock sustain bullish trend into 2025Rate Hike & Smart Investment Allocation Insights - Улправда
Raymond James Keeps Their Hold Rating on Teleflex (TFX) - The Globe and Mail
Is Teleflex Incorporated stock undervalued after correctionEarnings Risk Report & Verified Technical Trade Signals - Улправда
What risks investors should watch in Teleflex Incorporated stockEarnings Summary Report & Reliable Trade Execution Plans - Улправда
Teleflex Inc. stock underperforms Friday when compared to competitors - MarketWatch
Will Teleflex Incorporated stock enhance shareholder valueJuly 2025 Summary & Risk Managed Trade Strategies - Улправда
Why retail investors favor Teleflex Incorporated stockJuly 2025 Update & Verified Entry Point Signals - DonanımHaber
How Teleflex Incorporated stock trades pre earnings2025 Dividend Review & AI Forecasted Entry and Exit Points - Bölüm Sonu Canavarı
Will Teleflex Incorporated stock outperform growth indexesJuly 2025 Reactions & Long-Term Safe Investment Plans - DonanımHaber
Is Teleflex Incorporated stock a good choice for value investorsWeekly Stock Summary & AI Powered Market Trend Analysis - DonanımHaber
Why Teleflex Incorporated stock attracts global investorsShort Setup & Weekly Breakout Watchlists - DonanımHaber
What momentum indicators show for Teleflex Incorporated stockJuly 2025 Big Picture & Daily Profit Focused Screening - Улправда
Why Teleflex Incorporated (TBH) stock signals breakout potential2025 Winners & Losers & Safe Entry Point Identification - Улправда
Teleflex Announces FDA Clearance for Expanded Use of QuikClot Control+ Hemostatic Device - MSN
Is Teleflex Incorporated stock cheap by valuation metricsMarket Growth Summary & Safe Capital Allocation Plans - Улправда
Teleflex (TFX) Analyst Ratings Update: Truist Securities Revises Price Target | TFX Stock News - GuruFocus
Truist Securities Adjusts Price Target on Teleflex to $135 From $120, Maintains Hold Rating - marketscreener.com
Coloplast annoncerer ændringer i ledelsesteamet - GlobeNewswire Inc.
Intersurgical Acquires Teleflex Acute Care, Interventional Urology - respiratory-therapy.com
RBC Adjusts Price Target on Teleflex to $135 From $120, Maintains Sector Perform Rating - marketscreener.com
Should You Retain Teleflex Stock in Your Portfolio Now? - Yahoo Finance
Teleflex Inc. stock outperforms competitors despite losses on the day - MarketWatch
Teleflex strikes $2 billion asset sale, clears path for buybacks and focused growth - MSN
Teleflex Strikes $2 Billion Asset Sale, Clears Path for Buybacks and Focused Growth - MyChesCo
Deals tracker: Cencora to acquire OneOncology - Modern Healthcare
Teleflex sells acute care and urology businesses for $2.03 billion - Today's Medical Developments
Teleflex to sell acute care, interventional urology, OEM units for $2.03B - MSN
Teleflex Reports Q1 2025 Results and Revises Full-Year Guidance - MSN
Medtech in a Minute: Teleflex Divestment & More - Medical Device and Diagnostic industry
Teleflex (NYSE:TFX) Shares Rise After Vascular Acquisition News - Kalkine Media
Wayne’s Teleflex to Sell Three Business Divisions in Two Separate Deals - VISTA.Today
Teleflex Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Wells Fargo Maintains Teleflex (TFX) Equal-Weight Recommendation - Nasdaq
Teleflex: Selling, But How Much? (NYSE:TFX) - Seeking Alpha
Teleflex (TFX) Receives Updated Analyst Rating from Wells Fargo - GuruFocus
Teleflex to sell 3 medical technology divisions for a combined $2B - The Business Journals
Teleflex Sells Acute Care, Urology, and Medtech OEM Businesses in $2B Deal - PlasticsToday
Teleflex inks deals to sell 3 businesses for $2B - MedTech Dive
Teleflex to sell trio of business lines in deals totalling over $2bn - Yahoo Finance
US: Montagu and Kohlberg to carve out Teleflex Medical OEM for US$1.5bn - Investors in Healthcare
Teleflex Incorporated Azioni (TFX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.33%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):